- 您 可 以 信 任 的 醫 學 圖 書 智 庫 |
|
www.leaderbook.com.tw
Drug-Induced Diseases 2/E 2010
-藥劑科
- 編號: 0-000000001585282050
- 作者:James E. Tisdale
- 原價-5270 - (熱賣價)4929 - 節省 ↓6%
- 加入購物車
推薦指數:
- 內容介紹
Drug-Induced Diseases: Prevention, Detection, and Management, 2nd Edition
By James E. Tisdale, PharmD, BCPS, FCCP and Douglas A. Miller, Pharm.D.
2010; Approx. 1,000 pages; hardcover
P2050; ISBN: 978-1-58528-205-0
A drug-induced disease is the unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result of morbidity and/or mortality associated with drug-induced diseases. Despite best efforts to assure that all drugs are safe and effective, millions of patients each year develop drug-induced diseases. Every time a patient presents with a new disease or an exacerbation of an existing condition, the clinician should ask, "Could this be drug-related?"
Now in its second edition, this essential and comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. Edited by James E. Tisdale and Douglas A. Miller, with contributions from experts distinguished in their respective specialties, Drug-Induced Diseases is organized logically and is easy to use for pharmacists, physicians, nurses, and pharmacy students alike.
Inside you'll find:
Chapters dedicated to over 50 disease states.
In-depth tables, including coverage of drugs implicated in drug-induced diseases, epidemiology, mechanisms, signs and symptoms, risk factors, prevention, and management are included in each chapter.
A new chapter on Drug Safety and Drug-Induced Diseases: The Legal, Regulatory, and Practice Environment.
A new chapter on "Evaluating Patients for Drug-Induced Disease".
The inclusion of the Levels of Evidence classification for identifying the “strength of evidence” that links a listed drug to a specific drug-induced disease.
|
|
|
|
|